Genetic Polymorphisms of Xenobiotics-Metabolizing Enzymes Contributing to Leukemia
Polymorphisms in xenobiotic-metabolizing enzymes have been linked to an increased risk of developing leukemia (XMEs). XMEs are found in all higher organisms and are one of the first lines of defense against environmental chemicals. Toxins, including therapeutic agents, are completely metabolized and...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84079 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Genetic Polymorphisms of Xenobiotics-Metabolizing Enzymes Contributing to Leukemia
- Do Cytochrome P450 Enzymes Contribute to the Metabolism of Xenobiotics in Human?
- Pharmacogenomics Dictate Pharmacokinetics: Polymorphisms in Drug-Metabolizing Enzymes and Drug-Transporters
- Intradiol Dioxygenases — The Key Enzymes in Xenobiotics Degradation
- Phytochelatin Synthase in Heavy Metal Detoxification and Xenobiotic Metabolism
- Metabolic Optimization by Enzyme-Enzyme and Enzyme-Cytoskeleton Associations
- Genetics of Acute Lymphoblastic Leukemia